UA105211C2 - Хиноксалиновые производные и их применение для лечения доброкачественных и злокачественных опухолевых заболеваний - Google Patents
Хиноксалиновые производные и их применение для лечения доброкачественных и злокачественных опухолевых заболеванийInfo
- Publication number
- UA105211C2 UA105211C2 UAA201111539A UAA201111539A UA105211C2 UA 105211 C2 UA105211 C2 UA 105211C2 UA A201111539 A UAA201111539 A UA A201111539A UA A201111539 A UAA201111539 A UA A201111539A UA 105211 C2 UA105211 C2 UA 105211C2
- Authority
- UA
- Ukraine
- Prior art keywords
- tumour disorders
- malignant tumour
- quinoxaline derivatives
- treating benign
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Согласно этому изобретению предложенные хиноксалины общей формулы I, которые применяются как лекарственные средства для лечения опухолевых заболеваний, в частности в случаях резистентности к другим активных соединений или в случаях карциномы, которая метастазирует.Возможные области применения не ограничиваются опухолевыми заболеваниями.Формула I
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09157141A EP2241557A1 (de) | 2009-04-02 | 2009-04-02 | Chinoxalin-Derivate und deren Anwendung zur Behandlung gutartiger und bösartiger Tumorerkrankungen |
PCT/EP2010/053891 WO2010115719A1 (en) | 2009-04-02 | 2010-03-25 | Quinoxaline derivatives and their use for treating benign and malignant tumour disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
UA105211C2 true UA105211C2 (ru) | 2014-04-25 |
Family
ID=40886691
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201111539A UA105211C2 (ru) | 2009-04-02 | 2010-03-25 | Хиноксалиновые производные и их применение для лечения доброкачественных и злокачественных опухолевых заболеваний |
Country Status (20)
Country | Link |
---|---|
US (1) | US8394801B2 (ru) |
EP (2) | EP2241557A1 (ru) |
JP (1) | JP5583201B2 (ru) |
KR (1) | KR20110136888A (ru) |
CN (1) | CN102378758A (ru) |
AR (1) | AR075935A1 (ru) |
AU (1) | AU2010233983A1 (ru) |
BR (1) | BRPI1010306A2 (ru) |
CA (1) | CA2757138A1 (ru) |
CO (1) | CO6501171A2 (ru) |
EC (1) | ECSP11011363A (ru) |
IL (1) | IL215025A0 (ru) |
MX (1) | MX2011010329A (ru) |
NZ (1) | NZ595064A (ru) |
PE (1) | PE20120766A1 (ru) |
RU (1) | RU2532914C2 (ru) |
SG (1) | SG175014A1 (ru) |
TW (1) | TWI464150B (ru) |
UA (1) | UA105211C2 (ru) |
WO (1) | WO2010115719A1 (ru) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102464675A (zh) * | 2010-11-12 | 2012-05-23 | 上海医药工业研究院 | 具有抗肿瘤活性的金络合物及其可药用衍生物 |
MX2014000963A (es) | 2011-07-26 | 2014-03-27 | Gruenenthal Gmbh | Derivados de carboxamida y urea aromaticos biciclicos sustituidos como ligandos del receptor de vanilloide. |
US10517870B2 (en) | 2015-07-30 | 2019-12-31 | Bristol-Myers Squibb Company | Aryl substituted bicycle heteroaryl compounds |
CN115028617A (zh) * | 2016-05-24 | 2022-09-09 | 基因泰克公司 | Cbp/ep300的杂环抑制剂及其在治疗癌症中的用途 |
CN110698418B (zh) * | 2019-09-11 | 2022-07-01 | 广西师范大学 | 一种3-芳胺基喹喔啉-2-甲酰胺类衍生物及其制备方法和应用 |
CN115463217B (zh) * | 2021-06-11 | 2024-03-12 | 深圳埃格林医药有限公司 | 己酸羟孕酮在增强肿瘤治疗效果中的应用 |
CN114605391B (zh) * | 2022-02-21 | 2024-01-26 | 广州六顺生物科技股份有限公司 | 喹喔啉类衍生物及其制备方法和应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPN842196A0 (en) | 1996-03-05 | 1996-03-28 | Fujisawa Pharmaceutical Co., Ltd. | New compound |
IL133007A (en) | 1997-05-28 | 2005-06-19 | Aventis Pharma Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
US6180632B1 (en) | 1997-05-28 | 2001-01-30 | Aventis Pharmaceuticals Products Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
US6245760B1 (en) | 1997-05-28 | 2001-06-12 | Aventis Pharmaceuticals Products, Inc | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
US6159978A (en) | 1997-05-28 | 2000-12-12 | Aventis Pharmaceuticals Product, Inc. | Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinases |
JP3231338B2 (ja) | 1998-06-01 | 2001-11-19 | 塩野義製薬株式会社 | シアノイミノキノキサリン誘導体 |
UA76977C2 (en) * | 2001-03-02 | 2006-10-16 | Icos Corp | Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers |
WO2003101444A1 (en) * | 2002-05-29 | 2003-12-11 | Millennium Pharmaceuticals, Inc. | Diarylurea compounds and derivatives as chk-1 inhibitors for the treatment of cancer |
US20070254894A1 (en) | 2006-01-10 | 2007-11-01 | Kane John L Jr | Novel small molecules with selective cytotoxicity against human microvascular endothelial cell proliferation |
WO2008015423A1 (en) | 2006-08-01 | 2008-02-07 | Sentinel Oncology Limited | Quinoline and quinoxaline n-oxides as chk-1 inhibitors |
EP1990342A1 (en) * | 2007-05-10 | 2008-11-12 | AEterna Zentaris GmbH | Pyridopyrazine Derivatives, Process of Manufacturing and Uses thereof |
PE20090288A1 (es) | 2007-05-10 | 2009-04-03 | Smithkline Beecham Corp | Derivados de quinoxalina como inhibidores de la pi3 quinasa |
-
2009
- 2009-04-02 EP EP09157141A patent/EP2241557A1/de not_active Withdrawn
-
2010
- 2010-03-25 MX MX2011010329A patent/MX2011010329A/es active IP Right Grant
- 2010-03-25 AU AU2010233983A patent/AU2010233983A1/en not_active Abandoned
- 2010-03-25 PE PE2011001740A patent/PE20120766A1/es not_active Application Discontinuation
- 2010-03-25 WO PCT/EP2010/053891 patent/WO2010115719A1/en active Application Filing
- 2010-03-25 RU RU2011138477/04A patent/RU2532914C2/ru not_active IP Right Cessation
- 2010-03-25 BR BRPI1010306A patent/BRPI1010306A2/pt not_active IP Right Cessation
- 2010-03-25 KR KR1020117026033A patent/KR20110136888A/ko not_active Application Discontinuation
- 2010-03-25 EP EP10710051A patent/EP2419411A1/en not_active Withdrawn
- 2010-03-25 NZ NZ595064A patent/NZ595064A/xx unknown
- 2010-03-25 TW TW099108919A patent/TWI464150B/zh not_active IP Right Cessation
- 2010-03-25 AR ARP100100940A patent/AR075935A1/es unknown
- 2010-03-25 US US12/731,243 patent/US8394801B2/en not_active Expired - Fee Related
- 2010-03-25 CN CN201080014936XA patent/CN102378758A/zh active Pending
- 2010-03-25 CA CA2757138A patent/CA2757138A1/en not_active Abandoned
- 2010-03-25 UA UAA201111539A patent/UA105211C2/ru unknown
- 2010-03-25 JP JP2012502582A patent/JP5583201B2/ja not_active Expired - Fee Related
- 2010-03-25 SG SG2011071610A patent/SG175014A1/en unknown
-
2011
- 2011-09-07 IL IL215025A patent/IL215025A0/en unknown
- 2011-09-30 CO CO11128635A patent/CO6501171A2/es active IP Right Grant
- 2011-09-30 EC EC2011011363A patent/ECSP11011363A/es unknown
Also Published As
Publication number | Publication date |
---|---|
PE20120766A1 (es) | 2012-07-19 |
CN102378758A (zh) | 2012-03-14 |
KR20110136888A (ko) | 2011-12-21 |
WO2010115719A1 (en) | 2010-10-14 |
AR075935A1 (es) | 2011-05-04 |
CO6501171A2 (es) | 2012-08-15 |
RU2011138477A (ru) | 2013-05-10 |
EP2419411A1 (en) | 2012-02-22 |
TW201100391A (en) | 2011-01-01 |
TWI464150B (zh) | 2014-12-11 |
JP2012522741A (ja) | 2012-09-27 |
SG175014A1 (en) | 2011-11-28 |
JP5583201B2 (ja) | 2014-09-03 |
NZ595064A (en) | 2013-10-25 |
ECSP11011363A (es) | 2011-10-31 |
RU2532914C2 (ru) | 2014-11-20 |
US20100266538A1 (en) | 2010-10-21 |
EP2241557A1 (de) | 2010-10-20 |
US8394801B2 (en) | 2013-03-12 |
IL215025A0 (en) | 2011-11-30 |
MX2011010329A (es) | 2011-10-17 |
CA2757138A1 (en) | 2010-10-14 |
AU2010233983A1 (en) | 2011-10-06 |
BRPI1010306A2 (pt) | 2017-05-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013001970A (es) | Compuestos de pirrolopirimidina y usos de los mismos. | |
UA105211C2 (ru) | Хиноксалиновые производные и их применение для лечения доброкачественных и злокачественных опухолевых заболеваний | |
JO3366B1 (ar) | مثبطات بيرازوليل كوينوكزالين كاينيز | |
PH12017502141A1 (en) | Compounds and their methods of use | |
MX343706B (es) | Derivados heterocíclicos novedosos. | |
GEP201706691B (en) | Substituted phthalazin-1 (2h)-one derivatives as selecti- ve inhibitors of poly (adp-ribose) polymerase-1 | |
TN2012000108A1 (en) | Sustituted (heteroarylmethyl) thiohydantoins as anticancer drugs | |
MX360404B (es) | Compuestos para inhibir la proliferacion celular en canceres transmitidos por egfr. | |
MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
MX357502B (es) | Derivados de pirrolotriazinona. | |
PH12014501829A1 (en) | Bicyclic pyrazinone derivatives | |
BR112013008523A2 (pt) | compostos de piridazina carboxamida substituídos | |
MX2018003563A (es) | Nuevos compuestos. | |
MX336761B (es) | Compuestos para el tratamiento de cancer. | |
NZ702253A (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
IN2015DN01328A (ru) | ||
BR112013009260A2 (pt) | compostos de carboxamida de piridazina substituídos como compostos inibidores de quinase | |
MD3996C2 (ru) | Перхлораты 5-салицилиден-4-фенилтиосемикарбазонато(1-)-аквамеди(II), обладающие свойствами ингибиторов активности энзима 17b-HSD (типа 1) | |
MX2011006532A (es) | Compuestos anticancerigenos. | |
TW200621270A (en) | Novel use of nanogold for manufacturing medicaments for inhibiting metastasis of malignant tumors and growth of leukemic cells, and pharmaceutical compositions for inhibiting metastasis of malignant tumors and for treating leukemia comprising nanogold | |
AU2015373422A8 (en) | New imidazo[1,2-a]quinoxalines and derivates thereof for the treatment of cancer | |
TN2013000327A1 (en) | Novel heterocyclic derivatives | |
EP2575766A4 (en) | NEW PHARMACEUTICAL COMPOUNDS | |
MX2017007648A (es) | Composicion farmaceutica que comprende compuesto biciclico de amida heterociclica aromatica que contiene nitrogeno como ingrediente activo. | |
GB2519004A (en) | Quinone compounds and their uses for the treatment of cancer |